ICYMI: PhRMA CEO speaks at STAT Summit about government price setting

As part of the annualSTAT Summit, PhRMA President and CEO Stephen J. Ubl recently spoke withSTAT’s Matthew Herperto discuss the many unintended consequences expected from the latest drug pricing plan on Capitol Hill, as well as the biopharmaceutical industry ’s plans to help build a better health care system that improves patient access and protects innovation.
Source: The Catalyst - Category: Pharmaceuticals Tags: Drug Cost Medicare Out-of-Pocket Costs Polling Proactive Agenda Source Type: news